A new kind of drug for schizophrenia promises fewer side effects

Photo caption: The Food and Drug Administration approved Cobenfy, a twice-a-day medication that is a new kind of treatment for schizophrenia in adults. Photo credit: Steve Belkowitz / Bristol Myers Squibb. Article by Sydney Lupkin. NPR – September 27, 2024.

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called Cobenfy, though it had been referred to as KarXT during development. Its main advantage is that it appears to have fewer side effects than current medicines. […]

Click here to view original web page at www.npr.org